Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Jun 17th, 4:04 PM EDT
Detailed Quote
| Previous Close | 29.20 |
|---|---|
| Open | - |
| Bid | - |
| Ask | - |
| Day's Range | N/A - N/A |
| 52 Week Range | 25.15 - 33.59 |
| Volume | 0 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
Study Finds the Overall Prevalence of Psoriasis in the US Unchanged
A recently published analysis that appeared in the Journal of American Academy of Dermatology has concluded that the general percentage of adults in the U.S. diagnosed with psoriasis remains unchanged at 3% over the past 10 years. However, the investigators mention several points of concern that aren’t reflected in this general summary.
Via Investor Brand Network · June 17, 2025
Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet’s Disease
Behçet’s disease is a rare, chronic autoimmune disorder characterized by inflammation of blood vessels, leading to a range of symptoms including painful mouth and genital ulcers, eye inflammation and skin lesions. With limited treatment options available, Soligenix (NASDAQ: SNGX) is at the forefront of developing innovative therapies, notably SGX945 (dusquetide), aiming to address the unmet need in this challenging disease landscape ( https://ibn.fm/KByRu ).
Via Investor Brand Network · June 17, 2025
OTOFIX has just introduced the D1 Lite, a compact diagnostic tool designed for small garages, mobile technicians, and students in training. Available at https://otofix.store , it offers key diagnostic features typically found in higher-end models at a price point meant to support independent repair professionals and learners alike.
Via Get News · June 16, 2025
SLRspeed Launches New Performance Upgrades to Dominate the 2025 Drift and Street Scene
June 13, 2025 - Stuart, FL, USA - SLRspeed, a leader in precision-engineered drifting and racing parts, continues to push the boundaries of performance in 2025 with expanded product lines and technical resources aimed at enthusiasts, professionals, and DIY builders alike.
Via AB Newswire · June 13, 2025
CHIGEE, a pioneer in smart mobility, has officially launched the AIO-5 Smart Riding System—marking a significant leap forward in the integration of motorcycle technology with real-world riding needs.
Via AB Newswire · June 13, 2025
New Study Shows TTFields Amplify Immune Attack Against Brain Cancer
Breakthrough research conducted by a team at the University of Southern California (USC) has found that electric fields, administered through a device placed on a patient’s scalp, can supercharge the immune system’s ability to combat glioblastoma and increase the survival time of the patient.
Via Investor Brand Network · June 13, 2025
Nutriband Inc. (NASDAQ: NTRB) Reports Double-Digit Revenue Increase, Continued Progress on AVERSA Fentanyl Development
A wave of positive developments continues to build momentum for Nutriband (NASDAQ: NTRB), with recent capital funding, strategic partnerships and an expanded intellectual property portfolio reinforcing its bid to lead in the development of safer transdermal therapies. Nutriband is positioning itself at the forefront of abuse-deterrent drug delivery by advancing its Aversa platforms, notably its flagship fentanyl patch and buprenorphine candidates.
Via Investor Brand Network · June 12, 2025
Study Finds Kids with MS Biologically Age Faster Than Those Without It
New research conducted by UC San Diego researchers has revealed that adolescents and children having multiple sclerosis exhibit accelerated biological ageing . These findings were published in the journal Neurology . This study suggests that the changes linked to ageing could be happening earlier than had initially been thought among patients with MS.
Via Investor Brand Network · June 12, 2025
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics to Present at H.C. Wainwright Neuro Perspectives Conference
NRx Pharmaceuticals (NASDAQ: NRXP) and its wholly owned subsidiary HOPE Therapeutics, Inc. announced participation in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference, set for June 16–17, 2025. Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx and Co-CEO of HOPE, will deliver a corporate presentation highlighting recent developments, available on demand to registered attendees starting at 7 a.m. ET on June 16. The company will also conduct one-on-one investor meetings during the event.
Via Investor Brand Network · June 12, 2025
AUSTIN, Texas, June 12, 2025 (SEND2PRESS NEWSWIRE) -- Autocraft Bodywerks is proud to announce the opening of its fourth state-of-the-art collision repair center, located on State Highway 71 in Spicewood, Texas. This new 23,000-square-foot facility has achieved I-CAR Gold Class status and is proudly sponsored by BMW of South Austin and Audi of South Austin, as it works toward becoming the only BMW and Audi-certified collision repair center in the area. The company's expanded footprint, led by Manager Robbie Mulderrig will better serve customers in West Austin, Westlake, Bee Cave, Lakeway, Spicewood, and the surrounding communities. - News from Autocraft Bodywerks, issued by Send2Press Newswire
Via Send2Press · June 12, 2025
Nvidia announced a flurry of alliances with European companies and governments that extend its influence in AI across the continent.
Via Investor's Business Daily · June 11, 2025
Adageis Allows Healthcare Providers Maximum Value-Based Care Revenue with Simplicity and Visibility
As healthcare shifts further toward value-based care, one challenge continues to frustrate providers: understanding how care quality translates into financial outcomes. Adageis, a growing healthcare technology company with a patented AI-driven platform, is offering providers tools that both simplify operations and improve financial performance under value-based care models.
Via Investor Brand Network · June 11, 2025
Nvidia announces collaborations with European countries and companies to build world's first industrial AI cloud, including partnerships with software vendors and cloud providers.
Via Benzinga · June 11, 2025
Atlanta, GA () June 10, 2025 -- Luxury ground transportation in Atlanta gets an upgrade with Atlanta Elite Limo’s larger fleet and new services.
Via Prodigy · June 10, 2025
Celebrity Announcements of Breast Cancer Underscore Increasing Prevalence in Younger Women
Many young celebrities have recently announced that they have been diagnosed with breast cancer . This is a clear pointer to the public that cases of this disease among younger women not yet 50 years of age are rising in America.
Via Investor Brand Network · June 10, 2025
BioMedNewsBreaks — Panna Sharma, Lantern Pharma CEO, Says FDA’s Elsa AI Rollout Underscores Urgency to Modernize
Panna Sharma, CEO of Lantern Pharma, commented on the U.S. Food and Drug Administration’s launch of its new AI tool in PharmaVoice , stating: “The timeline is aggressive, especially given that the scope and rigor of the initial pilot testing wasn’t fully showcased, but this reflects the urgency FDA feels.” His remarks highlight the rapid pace at which the agency is moving to integrate artificial intelligence into its regulatory infrastructure.
Via Investor Brand Network · June 9, 2025
Limo SF VIP (+1-888-888-0195) has expanded their VIP chauffeur service for airport transfers, wine tours, corporate travel, and luxury events, available across San Francisco and the Bay Area.
Via Press Release Distribution Service · June 9, 2025
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
Nutriband (NASDAQ: NTRB) has been granted U.S. patent No. 12,318,492 for its “Abuse and Misuse Deterrent Transdermal Systems,” further strengthening domestic protection for its Aversa(TM) technology. The patent, issued June 3, 2025, enhances the company’s intellectual property portfolio for abuse-deterrent transdermal products designed to curb misuse, diversion, and accidental exposure. Aversa(TM) is currently in development as part of Nutriband’s lead product, Aversa Fentanyl, which aims to be the first abuse-deterrent fentanyl patch on the market, with peak U.S. sales potential projected between $80 million and $200 million.
Via Investor Brand Network · June 9, 2025
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, recently attended the RISE25 conference to demonstrate its portable Intelligent Fingerprint Drug Screening System, continuing its push into the U.S. market for rapid, non-invasive screening technologies ( https://ibn.fm/1JSTS ).
Via Investor Brand Network · June 6, 2025
Soligenix Inc. (NASDAQ: SNGX) Offers Hope on the Horizon with HyBryte(TM) Treatment Targeting CTCL
Cutaneous T-cell lymphoma (“CTCL”) is a rare and debilitating form of non-Hodgkin’s lymphoma that primarily affects the skin, posing both physical and emotional challenges for those diagnosed. With limited treatment options available and no definitive cure, the need for innovative, safe and effective therapies is urgent. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is focused on developing and commercializing products to treat rare diseases. At the forefront of Soligenix’s pipeline is HyBryte(TM), a novel therapy aimed at treating early-stage CTCL.
Via Investor Brand Network · June 6, 2025
More American Doctors are Relocating to Canada, Citing Federal Government Issues
As U.S. news outlets focus on the economic turmoil triggered by tariffs, another story is quietly developing. More doctors trained and working in the U.S. are relocating to Canada and the reasons they are giving rotate around the actions and policies of the Trump administration.
Via Investor Brand Network · June 6, 2025
BioMedNewsBreaks — FDA Accelerates Launch of AI Tool Elsa, Raising Questions on Transparency and Oversight
The U.S. Food and Drug Administration (“FDA”) has fast-tracked the rollout of its AI tool, Elsa, originally planned for June 30, with Commissioner Dr. Marty Makary touting the launch as both “ahead of schedule and under budget.” Elsa is already streamlining workflows across the agency, reducing multiday review tasks to minutes, and handling administrative functions such as safety profile assessments, label comparisons, and protocol reviews. The tool is housed in a secure GovCloud environment and was not trained on industry-submitted data, according to Makary.
Via Investor Brand Network · June 6, 2025
Via The Motley Fool · June 5, 2025
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) to Host Webcast With CEO to Share Updates on Alzheimer’s and Parkinson’s Programs
Annovis Bio (NYSE: ANVS) announced it will host a live webcast on June 24, 2025, at 4:30 PM EDT, featuring President and CEO Maria Maccecchini, Ph.D. The event will provide updates on the company’s pivotal Phase 3 trial for early Alzheimer’s disease, recent FDA feedback on its Parkinson’s disease program, and other key initiatives. The webcast will include a brief presentation followed by a live Q&A session open to shareholders, patients, and other stakeholders.
Via Investor Brand Network · June 5, 2025
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Italian Clearance for Option to Acquire Biotech Firm Pincell
Scinai Immunotherapeutics (NASDAQ: SCNI) announced it has received regulatory clearance under Italy’s Golden Power regulation to proceed with its option to acquire 100% of Pincell S.r.l., an Italian biotech company. The approval, issued by Italy’s Coordination Group and Ministry of Health, supports Scinai’s strategic move to expand its inflammation and immunology pipeline. Pincell’s lead asset, PC111—a monoclonal antibody targeting the Fas/FasL pathway—holds Orphan Drug Designation in Pemphigus and is being developed for severe skin disorders. The acquisition remains subject to final conditions, including a €12 million grant decision expected later this summer.
Via Investor Brand Network · June 5, 2025